A European partner in Life Science

AddLife’s companies are performing well across the board, with stronger margins, good growth and increased cash flow. Our improvement efforts are yielding clear results, and our recently acquired companies are making a significant contribution to earnings growth. At the same time, we are actively pursuing further acquisitions.

At Ropox, the team develops flexible assistive devices that support independent living for users and create safer, easier working environments for caregivers. As part of the Homecare portfolio, Ropox contributes to barrier-free environments and ageing at home, helping improve quality of life while addressing growing healthcare, housing and rehabilitation needs globally.

AddLife acquires CoaChrom Diagnostica GmbH, an Austrian niche company specialising in advanced coagulation diagnostics for clinical laboratories and the pharmaceutical industry, with approximately EUR 10 million in sales and 10 employees. CoaChrom will become part of AddLife’s business area, Labtech, and will continue to operate under its own brand in line with AddLife’s decentralised business model. CoaChrom is an Austrian niche company focusing on advanced coagulation diagnostics for clinical laboratories and the pharmaceutical industry.

AddLife acquires BioSpectrum Ltd, a fast‑growing distributor of surgical solutions in the fields of urology, gynaecology and general surgery in the UK. The company will be included within AddLife’s Business Area Medtech. BioSpectrum generates an annual revenue of approximately GBP 6 million and has 16 employees.